Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve

Sponsor
Hospital Universitario La Fe (Other)
Overall Status
Unknown status
CT.gov ID
NCT02240342
Collaborator
(none)
20
1
1
18
1.1

Study Details

Study Description

Brief Summary

Women delay maternity and, as a consequence, available oocyte number and their quality decrease (9-18% of all IVF patients). Different treatment protocols have been developed nevertheless none of them optimal: the number of oocytes retrieved depends on the present ones. New generation of oocytes and follicles has been defended by some authors and bone marrow seems to be involved. What seems crucial is the niche that produces paracrine signals able to activate dormant cells and to attract undifferentiated cells from other tissues (homing). This phenomenon has been described by our group in other human reproductive tissues like endometrium. The purpose of the study is to improve ovarian reserve in unfertile women with poor ovarian reserve by means of bone marrow protective capacity.

Bone marrow progenitor cells will be delivered into the ovarian artery allowing them to colonize ovarian niche.

The study hypothesis is that bone marrow progenitor cells will improve ovarian reserve differentiating themselves into germ cells or, more likely, stimulating the niche to activate dormant follicles.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bone marrow transplant into ovarian artery
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Ovarian Rejuvenation: Regeneration of Ovarian Follicles in Women With Poor Ovarian Reserve by Autologous Transplantation of Bone Marrow Derived Progenitors Cells in Peripheral Blood. Pilot Study.
Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Mar 1, 2015
Anticipated Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Poor ovarian reserve women

Drug: Bone marrow transplant into ovarian artery
Bone marrow progenitors mobilized to peripheral blood, obtained by plasmapheresis and infused into the ovarian artery

Outcome Measures

Primary Outcome Measures

  1. Ovarian reserve [6 months]

    Measured by FSH-LH, oestradiol, AMH, antral follicle count

Secondary Outcome Measures

  1. Ovarian response to controlled ovarian stimulation [6 months]

    Number of MII oocytes obtained

Other Outcome Measures

  1. Take home baby [2 years]

    healthy new born after controlled ovarian stimulation, ICSI and ET.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • < or= 40 years old

  • FSH<15UI/L

  • poor ovarian response after controlled ovarian stimulation with conventional doses (<3 oocytes) or two episodes of poor ovarian response after ovarian stimulation with maximal doses even if young or normal ovarian reserve study.

  • Antral follicle count>2

  • 1 antral follicle in the perfused ovary

  • AMH between 0,5 and 3pmol/L

  • regular menstrual bleeding each 21-35 days

  • To be candidate to autologous hematopoietic progenitors transplantation

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Universitario La fe Valencia Spain 46026

Sponsors and Collaborators

  • Hospital Universitario La Fe

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Antonio Pellicer Martínez, Professor, Hospital Universitario La Fe
ClinicalTrials.gov Identifier:
NCT02240342
Other Study ID Numbers:
  • NEOFOL2014
First Posted:
Sep 15, 2014
Last Update Posted:
Sep 15, 2014
Last Verified:
Sep 1, 2014
Keywords provided by Dr. Antonio Pellicer Martínez, Professor, Hospital Universitario La Fe

Study Results

No Results Posted as of Sep 15, 2014